Rizatriptan Benzoate
Rizatriptan Benzoate is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Rizatriptan Benzoate; Generic name: RIZATRIPTAN BENZOATE; Manufacturer: A-S Medication Solutions.
| Brand name | Rizatriptan Benzoate |
|---|---|
| Generic name | RIZATRIPTAN BENZOATE |
| Manufacturer | A-S Medication Solutions |
| Used for | 1 INDICATIONS AND USAGE Rizatriptan benzoate tablets are indicated for the acute treatment of migraine with or without aura in adults and in pediatric patients 6 to 17 years old. Limitations of Use Rizatriptan benzoate tablets should only be used where a clear diagnosis of migraine has been established. If a patient has no response for the first migraine attack treated with rizatriptan benzoate tablets, the diagnosis of migraine should be reconsidered before rizatriptan benzoate tablets are administered to treat any subsequent attacks. Rizatriptan benzoate tablets are not indicated for use in the management of hemiplegic or basilar migraine [see Contraindications (4) ] . Rizatriptan benzoate |
| Dosage | 2 DOSAGE AND ADMINISTRATION Adults: 5 mg or 10 mg single dose; separate repeat doses by at least two hours; maximum dose in a 24-hour period: 30 mg (2.1) Pediatric patients 6 to 17 years: 5 mg single dose in patients less than 40 kg (88 lb); 10 mg single dose in patients 40 kg (88 lb) or more ( 2.2 ) Adjust dose if co-administered with propranolol (2.4) 2.1 Dosing Information in Adults The recommended starting dose of rizatriptan benzoate tablets is either 5 mg or 10 mg for the acute treatment o |
| Active ingredient(s) | RIZATRIPTAN BENZOATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=187204ef-5370-476a-84b1-e3c54b60c6c2 |